Gliptins
46 - 60 of
86 Results
Sort Results:
Article:
more emphasis on improving care of diabetes patients while also improving performance on quality measures
April 2014
Article:
Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes
November 2013
Article:
Nesina (nes-SEE-na, alogliptin) will compete in a crowded market of gliptins, or DPP-4 inhibitors, for type 2 diabetes
August 2013
Guideline:
Hypoglycemia and Diabetes: a Report of a Workgroup of the American Diabetes Association and the Endocrine Society (2013)
June 2013